Erdem, G. U., Bozkaya, Y., Ozdemir, N. Y., Demirci, N. S., Yazici, O., & Zengin, N. (2018). 5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) as a third-line chemotherapy treatment in metastatic gastric cancer, after failure of fluoropyrimidine, platinum, anthracycline, and taxane. Bosnian Journal of Basic Medical Sciences, 18(2), 170-177. https://doi.org/10.17305/bjbms.2017.2258